• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


37.5500 USD 0.0500 0.13%

As of 16:00:00 ET on 08/21/2014.

Snapshot for Akorn Inc (AKRX)

Open: 37.4600 Day's Range: 37.2500 - 37.8800 Volume: 688,438
Previous Close: 37.6000 52wk Range: 16.0000 - 38.6100 1-Yr Rtn: +130.51%

Stock Chart for AKRX

No chart data available.
  • AKRX:US 37.5700
  • 1D
  • 1M
  • 1Y
Interactive AKRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKRX

Current P/E Ratio (ttm) 78.7403
Estimated P/E(12/2014) 37.4152
Relative P/E vs. SPX 4.4393
Earnings Per Share (USD) (ttm) 0.4761
Est. EPS (USD) (12/2014) 1.0020
Est. PEG Ratio 1.1820
Market Cap (M USD) 3,903.97
Shares Outstanding (M) 104.13
30 Day Average Volume 1,118,996
Price/Book (mrq) 13.2740
Price/Sale (ttm) 9.0911
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 08/29/1991
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AKRX

Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.

Rajat Rai "Raj"Chief Executive OfficerTimothy A Dick "Tom"CFO/Investor Relations
Bruce KutinskyChief Operating OfficerMark M SilverbergExec VP: Quality Assurance
More Company Profile & Key Executives for AKRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil